A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Applying to Emory University Hospital Midtown · Atlanta, Georgia
Answer a few short questions to share with the research team.